semaglutide 6 mg A new pill form of GLP-1 is making the weight loss drug more accessible Wegovy (Semaglutide): Uses, Side Effects,

GI symptoms elevate electrolyte risk

These medications originated to treat type 2 diabetes , and were later approved in the US for weight loss by the Food and Drug Administration (FDA) under Ozempic and Wegovy brand names

A 2023 study in Diabetes Care noted that GLP-1 agonists reduce systemic inflammation markers in patients with metabolic syndrome

Mild bruising is normal and typically resolves within days

Liraglutide, given once daily by injection (3.0 mg), was the first GLP-1 receptor agonist to be approved by the FDA and European Medicines Agency (EMA) for the treatment of obesity

In addition to hydration, DRIPBaR IV Therapy accelerates recovery by replenishing essential vitamins, minerals, and nutrients